There are four reports in today’s news of any real interest to the patient community. They deal with:
- The progress of the Prostate Cancer Clinical Trials Consortium
- Antiandrogens in prevention of prostate cancer (maybe)
- Disseminated tumor cells and prostate cancer progression
- Oral fenretinide in treatment of biochemical relapse after first-line therapy … READ MORE …
Filed under: Drugs in development, Management, Prevention, Treatment | Tagged: antiadrogens, disseminated tumor cells, fenretinine, Prevention, Prostate Cancer Clinical Trials Consortium | Leave a comment »